by Symmetron | Jan 19, 2019
atrial fibrillation Economic evaluation of insertable cardiac monitors in detecting previously undiagnosed atrial fibrillation and subsequently moderating stoke risk in a high-risk population in the United Kingdom Presented at ESC Congress. August 25-29, 2018....
by Symmetron | Jan 17, 2019
Medically unexplained symptoms The cost of somatisation among the working-age population in England for the year 2008–2009 Mental Health in Family Medicine. 2010;7:71–84 Awards Any awards or notable things to say about this? Process \ A \ B \ C...
by Symmetron | Jan 17, 2019
Idiopathic Pulmonary Fibrosis A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK PharmacoEconomics. 2017 Apr;35(4):479-491 Authors Rinciog C, Watkins M, Chang S, Maher TM, LeReun C, Esser D, Diamantopoulos A Process \ An...
Recent Comments